1990-1991 survey of pharmacotherapies used in the treatment of cocaine abuse.

1990-1991 survey of pharmacotherapies used in the treatment of cocaine abuse. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

1990-1991 survey of pharmacotherapies used in the treatment of cocaine abuse. Abstract Text:

In order to assess the usefulness of pharmacotherapeutic agents in cocaine treatment, all 3,631 physician members of the American Society of Addiction Medicine (ASAM) were surveyed. Five hundred and two physicians indicated use of pharmacotherapies, involving treatment experiences with approximately 79,760 patients for cocaine detoxification, and with 37,166 patients for cocaine abstinence maintenance. For both detoxification and abstinence maintenance, the four most commonly prescribed medications were amantadine, bromocriptine, desipramine, and l-tryptophan. As expected, these four medications were also the preferred treatment by a majority of physicians expressing any preference. Some relatively new medications are also being tried for the treatment of cocaine abuse, specifically carbamazepine, fluoxetine, and Tropamine.

1990-1991 survey of pharmacotherapies used in the treatment of cocaine abuse. Publishing Authors By Initials

For similar disorders of environmental origin: substance-related disorders research abstracts see: disorders of environmental origin: substance-related disorders research

PUBMED ID PMID:

MEDLINE DATE:

1990-1991 survey of pharmacotherapies used in the treatment of cocaine abuse. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Journal of addictive diseases

VOLUME: 12

Page Numbers: 129-39

Journal Abbreviation:

ISSN: 1055-0887

DAY: 12

MONTH: 05

YEAR: 1993

1990-1991 survey of pharmacotherapies used in the treatment of cocaine abuse. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9107051

1990-1991 survey of pharmacotherapies used in the treatment of cocaine abuse. Keywords Mesh Terms:

KEYWORDS: Substance-Related Disorders

MESH TERMS: rehabilitation

Chemical & Substance for Abstract: 1990-1991 survey of pharmacotherapies used in the treatment of cocaine abuse. Information

Substance Name: Cocaine

Registry Number: 50-36-2

Grant and Affiliation Information for 1990-1991 survey of pharmacotherapies used in the treatment of cocaine abuse.

AFFILIATION: University of Minnesota School of Medicine, Minneapolis.

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Addict Dis

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

1990-1991 survey of pharmacotherapies used in the treatment of cocaine abuse Related Publications

• A randomized clinical trial of two telephone-delivered, mental health interventions for HIV-infected persons in rural areas of the United States.
• An in vivo injury model of posterolateral knee instability.
• Bone grafting the jaws in the 21st century: the use of platelet-rich plasma and bone morphogenetic protein.
• Change in the scenery: an ethnographic exploration of crack cocaine use in rural Ohio.
• Correspondence.
• Crack cocaine trajectories among users in a midwestern American city.
• Effects of chronic growth hormone and insulin-like growth factor 1 deficiency on osteoarthritis severity in rat knee joints.
• Effects of long-term estrogen replacement therapy on the prevalence and area of periarticular tibial osteophytes in surgically postmenopausal cynomolgus monkeys.
• Effects of methylphenidate on response to oral levodopa: a double-blind clinical trial.
• Efficacy of treatment of inflammatory cytologic abnormalities detected by papanicolaou smears: a pilot study.
• Exploring experimental sources of multiple protein conformations in structure-based drug design.
• Fall-related injuries among agricultural household members: Regional Rural Injury Study II (RRIS-II).
• Focus and VP ellipsis.
• Guidelines for improving breast health care in limited resource countries: the Breast Health Global Initiative.
• Measuring the influence of built neighborhood environments on walking in older adults.
• Mechanisms of odor receptor gene choice in Drosophila.
• Nicotinic acid and other therapies for raising high-density lipoprotein.
• Protein flexibility and species specificity in structure-based drug discovery: dihydrofolate reductase as a test system.
• Pseudomonas infection of the catheter exit site successfully managed with topical acetic acid.
• Reduced brain DHA content after a single reproductive cycle in female rats fed a diet deficient in N-3 polyunsaturated fatty acids.
• Respondent-driven sampling in the recruitment of illicit stimulant drug users in a rural setting: findings and technical issues.
• Rhizobium etli CE3 bacteroid lipopolysaccharides are structurally similar but not identical to those produced by cultured CE3 bacteria.
• Role of omega-3 fatty acids in brain development and function: potential implications for the pathogenesis and prevention of psychopathology.
• Role of the bypassed proximal intestine in the anti-diabetic effects of bariatric surgery.
• Short-hairpin RNA expressed from polymerase III promoters mediates RNA interference in mosquito cells.
• Specific brain regions of female rats are differentially depleted of docosahexaenoic acid by reproductive activity and an (n-3) fatty acid-deficient diet.
• The case of BiDil: a policy commentary on race and genetics.
• The molecular basis of CO2 reception in Drosophila.
• The relationship between executive functioning and dissociation.
• Therapeutic efficacy of selegiline in neurodegenerative disorders and neurological diseases.